President elect of the American Diabetes Association.
Professor of Medicine with appointments in the Division of Endocrinology, Metabolism and Diabetes, Division of Cardiology.
Professor of Physiology and Biophysics at the University of Anschutz Medical Campus, and director of the Lipid Clinic at the University of Colorado Hospital
He holds the Charles A. Boettcher II Endowed Chair in atherosclerosis at the University of Colorado Denver, where he is also a professor of medicine and professor of physiology and biophysics. In 2016 Eckel was among the recipients of the Laureate Awards of the Endocrine Society, as Outstanding Clinical Investigator. He has done significant research in the biology and pathophysiology of lipoprotein lipase.
Eckel was on the Scientific Advisory Council of the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health. His research area includes nutrition, insulin action, energy balance and body weight regulation.
Eckel is a former president of the American Heart Association, and a fellow of the American College of Cardiology and the American College of Physicians; he received the Robert H. Herman Award from the American Society for Nutrition in 2011.
Melanie Davies is a clinician with over 25 years experience working as a diabetologist and physician and since 2006 is Professor of Diabetes Medicine at the University of Leicester. She is an NIHR Senior Investigator, one of only a handful in diabetes in the UK, Director of the NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit, Director of a Clinical Trial Unit, Lead for Division 2 of the Clinical Research Network East Midlands and PI on a number of large global studies in the field of diabetes, obesity and cardiovascular disease. Professor Davies is the global PI on the SCALE Obesity trial, a large multinational study investigating management of obesity with GLP-1 analogue.
Professor of Medicine, specializing in endocrinology and angiology, at the Munich Diabetes Research Group e.V. at Helmholtz Centre. Dr. Standl's principal areas of research include diabetology, action and degradation of insulin and epidemiology of cardiovascular diabetic complications.
Previously, Dr. Standl was Director of the Department of Endocrinology, Diabetology and Metabolism at the Academic Hospital Munich-Schwabing. He also worked at the world-renowned Joslin Diabetes Center in Boston, Massachusetts. Dr. Standl served as a Member of Scientific Advisory Board at LabStyle Innovations Corp. since May 2014.
Dr. Standl has served as President of the German Diabetes Association, German Diabetes Union and International Diabetes Federation Europe as well as Vice President of the International Diabetes Federation and European Association for the Study of Diabetes (EASD).various scientific awards, most recently the Hellmut Mehnert Award at the IDF World Diabetes Congress 2013.
consultant physician at St Bartholomew's Hospital and Professor of Diabetes and Autoimmunity at the Blizard Institute, Queen Mary, University of London. He was recently elected President of The Association of Physicians of Great Britian and Ireland.
He qualified and trained at Imperial College and subsequently at King's College Hospital and Royal Victoria Infirmary, Newcastle. He was an MRC Travelling Fellow at the University of Chicago, USA, and Welcome Trust Senior Clincal Research Fellow at both King's College and Charing Cross and Westminster Medical Schools.
He has an interest in the cause of autoimmune diabetes through the study of twins and disease syndromes.
Professsor David Leslie has been Professor of Diabetes and Autoimmunity at the Blizard Institute, University of London He has published 12 books and more than 200 peer-reviewed papers and received grants from many agencies including the EU, Wellcome Trust and MRC. In 2012 he was elected President of the Association of Physicians of Great Britain and Ireland. He ran the Diabetes Department at St Bartholomews Hospital, London with extensive experience of all aspects of diabetes, having previously been a consultant at Kings College Hospital.
Professor of Diabetes and Clinical Research at the Centre for Diabetes at Barts and The London School of Medicine & Dentistry, London, and Professor of Endocrinology & Metabolic Diseases at the University Campus Bio-Medico in Rome, Italy.
He coordinates the International PhD programme in Endocrinology and Metabolic Diseases between Queen Mary University of London, University Campus Bio-Medico in Rome and the University of Ulm, Germany.
He is Member Scientific Advisory Board of the Graduate School in Molecular Medicine, University of Ulm, Member Advisory Board of the International Diabetes Federation, Group for Diabetes in the Youth and Delegate for University Campus Bio-Medico, Permanent Conference of Rectors of the Italian Universities (CRUI).
He is currently the European Editor of Diabetes Metabolism Research & Reviews, John Wiley Publ.
Director , EDC , Center for Diabetes Education
Editor , Annals of Internal Medicine , Middle East Edition
Member of the Michigan Center for Diabetes Translational Research MCDTR , Ann Arbor , Michigan
Amy Fischl, MS, RD, LDN, BC-ADM, CDE is a program coordinator for the Teen and Adolescent Diabetes Transition Program at the University of Chicago’s Kovler Diabetes Center. She is also a certified diabetes educator, nutrition specialist, and certified insulin pump trainer.
Her professional activities include writing CE test items for the American Association of Diabetes Educators, reviewing submissions for the Journal of the American Dietetic Association, and participating on the advisory boards of Nature’s Way, Dreamfields Pasta, and Jolly Time Popcorn.
She completed her undergraduate degree at Northern Illinois University in DeKalb, IL. While earning her Master of Science degree from Mount Mary College in Milwaukee, WI, she researched the effect evening snacks have on blood sugars of patients with type 1 diabetes.
Chief Physician at Slagelse Hospital
Endocrinology, Diabetes and Metabolism
Chief Physician, DMSc, Specialist in endocrinology, Specialist in internal medicine at Slagelse Hospital
Associate Professor at the University of Southern Denmark
Chief Physician at Slagelse Hospital
Assistant Professor of Clinical Medicine, Medicine , Weill Cornell Medical College 2013 - July 2006 Albert Einstein College of Medicine, Bronx, NY: The role of CD8-mediated cellular immunity in the pathogenesis of Type I Diabetes. NIH, JDRF, AECOM, PI: Dr. Teresa DiLorenzo. Sept 2003 Columbia University, NY NY: Analysis of genetic markers predicting response of newly-diagnosed Type I diabetes to anti-CD3 monoclonal antibody. Columbia University, PI: Dr. Kevin Herold. April 2002 Kumasi, Ghana: International Telemedicine. Emory University, PI: Dr. Kenneth Walker. July 2000 Tbilisi, Repulbic of Georgia: HIV and HCV sero-prevalence in known TB patients. Presented at the American Federation of Research Forum, New Orleans. Analysis of Buccal Smears for the Asian haplotype of mitochondrial DNA in native Caucasians living in the Republic of Georgia. Emory University, PI: Drs. Henry Blumberg and Carlos Del Rio. March 1998 Georgia Mental Health Institute, Atlanta, GA: Novel isolation techniques for legionella. Emory University, PI: Dr. Robert Benson. March 1998 Georgia Mental Health Institute, Atlanta, GA: Dopamine pathways involved in the etiology of Major Depression. Emory University, PI: Dr. Jay Weiss.
Professor, MD. Dr. Med. Sci. Department of Endocrinology and Metabolism, Aarhus University
He has been a member of the Danish Nutrition Council (1992 - 1995), chairman for the Danish Association for the Study of Obesity (1990 - 1994), member of the executive committee of the Danish Endocrine Society, and council member of the European Association for the Study of Obesity (EASO) (from 1994) and member of the executive committee of EASO (from 1996 to 2000 as secretary). Member of the Danish Medical Research Council ( 2001 - 2004 ). Vice-president in the Danish Nutrition Council (2001 -2002 ) and President for The Danish Nutrition Council from 2003.
Specialist in general and laparoscopic surgery, who, starting from September 1st, will take up service at the biomedical campus, the leading university polyclinic
John Buse, MD, PhD, is the Verne S. Caviness Distinguished Professor, Chief of the Division of Endocrinology, Director of the Diabetes Center, Director of the NC Translational and Clinical Sciences Institute and Executive Associate Dean for Clinical Research at the University of North Carolina (UNC) School of Medicine in Chapel Hill.
Dr. Buse received his MD and PhD from Duke University before training in internal medicine and endocrinology at the University of Chicago. He has been on the faculty at UNC since 1994. His efforts combines clinical care, research, administration and teaching. He has received international recognition for innovative patient-centered care. He works with teams of investigators in diabetes clinical trials, comparative effectiveness research and translation of basic science towards clinical application. He serves as Director of the NC Translational and Clinical Sciences Institute working through a NIH-based consortium to accelerate the conversion of ideas and discoveries to products and policies for the improvement of health and well-being. Dr. Buse completed service as President for Medicine & Science at the American Diabetes Association in 2008 and as Chair of the National Diabetes Education Program in 2014. He has received numerous awards and honors, including the 2010 Castle Connolly National Physician of the Year Award. He has authored more than 300 publications in journals including the New England Journal of Medicine, JAMA and Diabetes Care.